Effects of etanercept on the patient-perceived results (PROs) in patients with moderate-to-severe plaque psoriasis: systematic review of the literature and meta-analysis-Reference-Cited by-同舟云学术

Effects of etanercept on the patient-perceived results (PROs) in patients with moderate-to-severe plaque psoriasis: systematic review of the literature and meta-analysis

Published:2018-05-08 Issue:8 Volume:29 Page:806-811
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Carrascosa Jose Manuel¹^ORCID,Rebollo Francisco²,Gómez Susana²,De-la-Cueva Plablo³

Affiliation:

1. Dermatology Service, Hospital Germans Trias i Pujol, Barcelona, Spain;

2. Pfizer Medical Department, Alcobendas Madrid, Spain;

3. Dermatology Service, Infanta Leonor University Hospital, Madrid, Spain

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2018.1467536

Reference45 articles.

1. Prevalence of psoriasis in Spain (Epiderma Project: phase I)

2. Prevalencia de la psoriasis en España en la era de los agentes biológicos

3. Impacto de la psoriasis en la calidad de vida relacionada con la salud

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis;Italian Journal of Dermatology and Venereology;2022-03

2. German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-07

3. Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-07

4. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations;Journal of the European Academy of Dermatology and Venereology;2021-02

5. Estudio Delphi para el uso de apremilast en la psoriasis;Actas Dermo-Sifiliográficas;2020-03